On Monday, June 24, the next meeting of the Transparency Council.
The agenda includes:
1. Preparation of a position paper on the evaluation of the drug Acarizax (standardized allergenic extract of house dust mite (Dermatophagoides pteronyssinus, Dermatophagoides farina), Sublingual lyophilizate)) for the indication: treatment of adult patients (aged 18 to 65 years), whose diagnosis was made on the basis of clinical history and a positive allergic test to house dust mites (spot skin t...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
